Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2) (N-Term) Peptide
Quick Overview for Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2) (N-Term) Peptide (ABIN8099494)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- EGLN2 Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-EGLN2 antibody ( ARP34747_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
-
Background
-
Background Information: The hypoxia inducible factor (HIF) is a transcriptional complex which is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. EGLN2 encodes an enzyme responsible for this posttranslational modification. Alternative splicing of EGLN2 results in three transcript variants encoding different isoforms.
Alternative Symbols: EIT6, PHD1, HPH-1, HPH-3, HIFPH1, HIF-PH1
-
Molecular Weight
- 16kDa
-
Gene ID
- 112398
-
UniProt
- Q96KS0
Target
-